$XERI
XERIANT, INC. Stock $xeri

$xeri Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000147793223003889 Filed on May 23, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	-$710.0K	$240.8K	$342.5K
YoY Change	-151.85%	-70.82%	-70.65%
% of Gross Profit
Research & Development	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
% of Gross Profit
Depreciation & Amortization	$0.00	$380.00	$370.00
YoY Change	-100.0%	52.0%	362.5%
% of Gross Profit
Operating Expenses	$390.0K	$387.2K	$539.0K
YoY Change	-72.71%	-63.84%	-87.35%
Operating Profit		-$387.2K	-$539.0K
YoY Change		-63.84%	-87.35%
Interest Expense	-$50.00K	$0.00	$0.00
YoY Change	-97.01%	-100.0%	-100.0%
% of Operating Profit
Other Income/Expense, Net		-$2.498K	-$755.3K
YoY Change		-99.86%	-40.36%
Pretax Income	-$600.0K	-$389.7K	-$1.294M
YoY Change	-80.66%	-86.1%	-76.58%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$590.0K	-$369.1K	-$1.294M
YoY Change	-84.24%	-86.84%	-76.58%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	381.9M shares	376.9M shares	366.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$60.00K	$104.1K	$227.5K
YoY Change	-94.66%	-93.85%	-89.22%
Cash & Equivalents	$61.63K	$104.1K	$119.6K
Short-Term Investments			$107.9K
Other Short-Term Assets	$0.00	$14.75K	$23.07K
YoY Change	-100.0%	2.86%	50.1%
Inventory
Prepaid Expenses	$4.529K	$2.200K	$10.52K
Receivables
Other Receivables
Total Short-Term Assets	$66.15K	$118.8K	$250.6K
YoY Change	-94.18%	-93.04%	-88.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.507K	$5.885K	$6.263K
YoY Change	24.9%	-70.06%	27.63%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$0.00	$153.8K
YoY Change	-100.0%
Other Assets	$10.00K
YoY Change	0.0%
Total Long-Term Assets	$101.0K	$254.4K	$112.5K
YoY Change	-23.94%	60.4%	-27.05%
TOTAL ASSETS
Total Short-Term Assets	$66.15K	$118.8K	$250.6K
Total Long-Term Assets	$101.0K	$254.4K	$112.5K
Total Assets	$167.1K	$373.3K	$363.1K
YoY Change	-86.84%	-80.0%	-84.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$400.0K	$189.3K	$158.0K
YoY Change	603.73%	457.42%	565.37%
Accrued Expenses	$80.00K	$86.17K	$114.7K
YoY Change	12.74%	187.23%	282.17%
Deferred Revenue
YoY Change
Short-Term Debt	$6.200M	$6.036M	$5.850M
YoY Change	57.51%	160.19%	711.31%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.751M	$6.386M	$6.198M
YoY Change	63.1%	164.07%	655.35%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$40.00K	$50.88K	$66.94K
YoY Change	-56.62%	-56.73%	-43.07%
Total Long-Term Liabilities	$40.00K	$50.88K	$66.94K
YoY Change	-56.62%	-56.73%	-43.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.751M	$6.386M	$6.198M
Total Long-Term Liabilities	$40.00K	$50.88K	$66.94K
Total Liabilities	$6.787M	$6.437M	$6.265M
YoY Change	60.4%	153.83%	567.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.64M	-$23.03M	-$22.67M
YoY Change	42.65%	79.55%	126.01%
Common Stock	$2.365M	$3.819K	$3.769K
YoY Change	64937.64%	5.12%	5.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.793M	-$3.245M	-$3.089M
YoY Change
Total Liabilities & Shareholders Equity	$167.1K	$373.3K	$363.1K
YoY Change	-86.84%	-80.0%	-84.08%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	-$590.0K	-$369.1K	-$1.294M
YoY Change	-84.24%	-86.84%	-76.58%
Depreciation, Depletion And Amortization	$0.00	$380.00	$370.00
YoY Change	-100.0%	52.0%	362.5%
Cash From Operating Activities	-$130.0K	-$93.25K	-$378.5K
YoY Change	-74.62%	-76.81%	-88.48%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$10.00K	-$192.3K
YoY Change	-91.33%
Cash From Investing Activities	-$10.00K	-$192.3K	$0.00
YoY Change	-91.33%	1181.73%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	100.0K	270.0K	0.000
YoY Change			-100.0%
NET CHANGE
Cash From Operating Activities	-130.0K	-93.25K	-378.5K
Cash From Investing Activities	-10.00K	-192.3K	0.000
Cash From Financing Activities	100.0K	270.0K	0.000
Net Change In Cash	-40.00K	-15.51K	-378.5K
YoY Change	-93.63%	-96.28%	-120.7%
FREE CASH FLOW
Cash From Operating Activities	-$130.0K	-$93.25K	-$378.5K
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$130.0K	-$93.25K	-$378.5K
YoY Change	-74.62%	-75.91%	-88.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	756	usd
CY2023Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	84000	usd
CY2022Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	12546	usd
CY2023Q1	us-gaap	Assets Assets	373254	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001481504
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	381933144	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	365239001	shares
CY2022Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00001
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-54277
	dei	Entity Registrant Name EntityRegistrantName	XERIANT, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1519178
	dei	Entity Address Address Line1 EntityAddressAddressLine1	Innovation Centre 1
	dei	Entity Address Address Line2 EntityAddressAddressLine2	3998 FAU Boulevard, Suite 309
	dei	Entity Address City Or Town EntityAddressCityOrTown	Boca Raton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33431
	dei	City Area Code CityAreaCode	561
	dei	Local Phone Number LocalPhoneNumber	491-9595
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	381933144	shares
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	104080	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1065945	usd
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	12546	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2200	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	118826	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1079247	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5885	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4409	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	94733	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	128342	usd
CY2023Q1	us-gaap	Investments Investments	153810	usd
CY2022Q2	us-gaap	Investments Investments	57678	usd
CY2022Q2	us-gaap	Assets Assets	1269676	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	189301	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	56836	usd
CY2023Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	32000	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	22000	usd
CY2023Q1	xeri	Shares To Be Issued Current SharesToBeIssuedCurrent	75200	usd
CY2022Q2	xeri	Shares To Be Issued Current SharesToBeIssuedCurrent	75200	usd
CY2023Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	5850000	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3936185	usd
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	185810	usd
CY2022Q2	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	54169	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	48963	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6386480	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4139184	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	50880	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	92197	usd
CY2023Q1	us-gaap	Liabilities Liabilities	6437360	usd
CY2022Q2	us-gaap	Liabilities Liabilities	4231381	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	381933144	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	365239001	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	3819	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	3637	usd
CY2023Q1	xeri	Common Stock To Be Issued CommonStockToBeIssued	51950	usd
CY2022Q2	xeri	Common Stock To Be Issued CommonStockToBeIssued	51950	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19730244	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	16351806	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23030565	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16571505	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-3244534	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-164094	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-2819572	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	-2797611	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6064106	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2961705	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	373254	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1269676	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	226107	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	799521	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1112184	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3120772	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	62445	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	102646	usd
	us-gaap	Professional Fees ProfessionalFees	231073	usd
	us-gaap	Professional Fees ProfessionalFees	234671	usd
CY2022Q1	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	135500	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	296000	usd
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	348925	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7587	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5207806	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	14688	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	25771	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	22987	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	670989	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	387240	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	1071025	usd
	us-gaap	Operating Expenses OperatingExpenses	1662244	usd
	us-gaap	Operating Expenses OperatingExpenses	9583163	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-387240	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1071025	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1662244	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-9583163	usd
CY2023Q1	xeri	Amortization Of Debt Discount AmortizationOfDebtDiscount	0	usd
CY2022Q1	xeri	Amortization Of Debt Discount AmortizationOfDebtDiscount	1598683	usd
	xeri	Amortization Of Debt Discount AmortizationOfDebtDiscount	461842	usd
	xeri	Amortization Of Debt Discount AmortizationOfDebtDiscount	3012642	usd
CY2023Q1	us-gaap	Loan Processing Fee LoanProcessingFee	20600	usd
CY2022Q1	us-gaap	Loan Processing Fee LoanProcessingFee	0	usd
	us-gaap	Loan Processing Fee LoanProcessingFee	20600	usd
	us-gaap	Loan Processing Fee LoanProcessingFee	43750	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	0	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	134927	usd
	us-gaap	Interest Expense InterestExpense	0	usd
	us-gaap	Interest Expense InterestExpense	138941	usd
CY2023Q1	xeri	Decrease Increase In Fair Value Of Convertible Bridge Loans DecreaseIncreaseInFairValueOfConvertibleBridgeLoans	817	usd
CY2022Q1	xeri	Decrease Increase In Fair Value Of Convertible Bridge Loans DecreaseIncreaseInFairValueOfConvertibleBridgeLoans	0	usd
	xeri	Decrease Increase In Fair Value Of Convertible Bridge Loans DecreaseIncreaseInFairValueOfConvertibleBridgeLoans	817	usd
	xeri	Decrease Increase In Fair Value Of Convertible Bridge Loans DecreaseIncreaseInFairValueOfConvertibleBridgeLoans	0	usd
CY2023Q1	xeri	Gain Loss From Ebenberg Jv GainLossFromEbenbergJv	18919	usd
CY2022Q1	xeri	Gain Loss From Ebenberg Jv GainLossFromEbenbergJv	0	usd
	xeri	Gain Loss From Ebenberg Jv GainLossFromEbenbergJv	-96131	usd
	xeri	Gain Loss From Ebenberg Jv GainLossFromEbenbergJv	0	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4259987	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-536	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2498	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1733613	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4839377	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3195869	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-369138	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2804638	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6481021	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12779032	usd
CY2023Q1	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-7229	usd
CY2022Q1	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-7425	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-21961	usd
	us-gaap	Income Loss Attributable To Noncontrolling Interest IncomeLossAttributableToNoncontrollingInterest	-3222294	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-382509	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2797213	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6479660	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9556738	usd
CY2023Q1	xeri	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.00
CY2022Q1	xeri	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.01
	xeri	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.02
	xeri	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.03
CY2023Q1	xeri	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	377710922	shares
CY2022Q1	xeri	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	362872609	shares
	xeri	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	372820541	shares
	xeri	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	339759839	shares
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-2961705	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	48000	usd
CY2022Q3	xeri	Conversion Of Series A Preferred To Common Stock Amount ConversionOfSeriesAPreferredToCommonStockAmount	0	usd
CY2022Q3	xeri	Fair Value Of Warrants Associated With Convertible Debt FairValueOfWarrantsAssociatedWithConvertibleDebt	1918393	usd
CY2022Q3	xeri	Adjustment For Rounding AdjustmentForRounding	0	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	306170	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-4817521	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5506663	usd
CY2022Q4	xeri	Conversion Of Series A Preferred To Common Stock Amount ConversionOfSeriesAPreferredToCommonStockAmount	0	usd
CY2022Q4	xeri	Fair Value Of Warrants Associated With Convertible Debt FairValueOfWarrantsAssociatedWithConvertibleDebt	689621	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	209747	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-1294362	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5901657	usd
CY2023Q1	xeri	Conversion Of Series A Preferred To Common Stock Amount ConversionOfSeriesAPreferredToCommonStockAmount	0	usd
CY2023Q1	xeri	Warrants Associated With Convertible Bridge Loans WarrantsAssociatedWithConvertibleBridgeLoans	80114	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	126575	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-369138	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6064106	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	705306	usd
CY2021Q3	xeri	Issuance Of Common Stock Committed In Prior Period Amount IssuanceOfCommonStockCommittedInPriorPeriodAmount	0	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1668500	usd
CY2021Q3	xeri	Shares Issued As Equity Kicker Amount SharesIssuedAsEquityKickerAmount	43753	usd
CY2021Q3	xeri	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	128550	usd
CY2021Q3	xeri	Conversion Of Series A Preferred To Common Stock Amount ConversionOfSeriesAPreferredToCommonStockAmount	0	usd
CY2021Q3	xeri	Conversion Of Convertible Notes And Accrued Interest Amount ConversionOfConvertibleNotesAndAccruedInterestAmount	173070	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	541100	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1060324	usd
CY2021Q3	xeri	Fair Value Of Beneficial Conversion Feature Associated With Convertible Debt FairValueOfBeneficialConversionFeatureAssociatedWithConvertibleDebt	250000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-4447915	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	122688	usd
CY2021Q4	xeri	Issuance Of Common Stock Committed In Prior Period Amount IssuanceOfCommonStockCommittedInPriorPeriodAmount	0	usd
CY2021Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	410000	usd
CY2021Q4	xeri	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	0	usd
CY2021Q4	xeri	Conversion Of Series A Preferred To Common Stock Amount ConversionOfSeriesAPreferredToCommonStockAmount	0	usd
CY2021Q4	xeri	Conversion Of Convertible Notes And Accrued Interest Amount ConversionOfConvertibleNotesAndAccruedInterestAmount	250000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	116104	usd
CY2021Q4	us-gaap	Share Based Compensation ShareBasedCompensation	827221	usd
CY2021Q4	xeri	Fair Value Of Warrants Associated With Convertible Debt FairValueOfWarrantsAssociatedWithConvertibleDebt	2777081	usd
CY2021Q4	xeri	Fair Value Of Beneficial Conversion Feature Associated With Convertible Debt FairValueOfBeneficialConversionFeatureAssociatedWithConvertibleDebt	2365419	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-5526483	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1342031	usd
CY2022Q1	xeri	Issuance Of Common Stock Committed In Prior Period Amount IssuanceOfCommonStockCommittedInPriorPeriodAmount	3749	usd
CY2022Q1	xeri	Conversion Of Series A Preferred To Common Stock Amount ConversionOfSeriesAPreferredToCommonStockAmount	0	usd
CY2022Q1	xeri	Inducment Of Conversion Interest Expense Amount InducmentOfConversionInterestExpenseAmount	134927	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	574563	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	79750	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2804638	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-669618	usd
	us-gaap	Profit Loss ProfitLoss	-6481021	usd
	us-gaap	Profit Loss ProfitLoss	-12779032	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1091	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	332	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	642492	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2462108	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	48000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	736954	usd
	xeri	Financing Fees FinancingFees	20600	usd
	xeri	Financing Fees FinancingFees	178676	usd
	xeri	Decrease In Fair Value Of Convertible Bridge Loans DecreaseInFairValueOfConvertibleBridgeLoans	817	usd
	xeri	Decrease In Fair Value Of Convertible Bridge Loans DecreaseInFairValueOfConvertibleBridgeLoans	0	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-4259987	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	0	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-96131	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	461842	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3012642	usd
	xeri	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-33609	usd
	xeri	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-30246	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-36111	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-31432	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1444	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	556	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-69171	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-35513	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	10000	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	5000	usd
	xeri	Increase Decrease In Accrued Expenses IncreaseDecreaseInAccruedExpenses	-3258	usd
	xeri	Increase Decrease In Accrued Expenses IncreaseDecreaseInAccruedExpenses	5520	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1037036	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6415055	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	192262	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2567	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19990	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-194829	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-19990	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2078500	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	128550	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	270000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	4958950	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	270000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7166000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-961865	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	730955	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1065945	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	962540	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	104080	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1693495	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	xeri	Conversion Of Convertible Notes Payable And Accrued Interest ConversionOfConvertibleNotesPayableAndAccruedInterest	0	usd
	xeri	Conversion Of Convertible Notes Payable And Accrued Interest ConversionOfConvertibleNotesPayableAndAccruedInterest	440995	usd
	xeri	Warrants Issued With Convertible Notes Payable WarrantsIssuedWithConvertibleNotesPayable	80114	usd
	xeri	Warrants Issued With Convertible Notes Payable WarrantsIssuedWithConvertibleNotesPayable	2894974	usd
	xeri	Beneficial Conversion Feature Arising From Convertible Notes Payable BeneficialConversionFeatureArisingFromConvertibleNotesPayable	0	usd
	xeri	Beneficial Conversion Feature Arising From Convertible Notes Payable BeneficialConversionFeatureArisingFromConvertibleNotesPayable	2787376	usd
CY2023Q1	us-gaap	Cash Cash	104080	usd
CY2022Q2	us-gaap	Cash Cash	1065945	usd
CY2023Q1	xeri	Working Capital WorkingCapital	-6093241	usd
CY2022Q2	xeri	Working Capital WorkingCapital	-3002259	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6481021	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12779032	usd
	us-gaap	Variable Interest Entity Ownership Percentage VariableInterestEntityOwnershipPercentage	0.64	pure
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The most significant assumptions and estimates relate to the valuation of beneficial conversion features and warrants associated with convertible debt. Actual results could differ from these estimates.</p>
CY2022	us-gaap	Debt Instrument Convertible Beneficial Conversion Feature DebtInstrumentConvertibleBeneficialConversionFeature	2615419	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7587	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5207806	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	1298	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	3690	usd
	us-gaap	Advertising Expense AdvertisingExpense	26058	usd
	us-gaap	Advertising Expense AdvertisingExpense	168403	usd
	xeri	Warrants Issued WarrantsIssued	108212161	shares
	xeri	Warrants Issued WarrantsIssued	55512161	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	18031250	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	7968750	shares
	xeri	Stock Issued During Period Convertible Notes Payable StockIssuedDuringPeriodConvertibleNotesPayable	50968829	shares
	xeri	Stock Issued During Period Convertible Notes Payable StockIssuedDuringPeriodConvertibleNotesPayable	50968829	shares
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	769395000	shares
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	769895000	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	946607240	shares
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	884344740	shares
	us-gaap	Cash Acquired In Excess Of Payments To Acquire Business CashAcquiredInExcessOfPaymentsToAcquireBusiness	0	usd
CY2022	us-gaap	Cash Acquired In Excess Of Payments To Acquire Business CashAcquiredInExcessOfPaymentsToAcquireBusiness	811429	usd
	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.10	pure
CY2023Q1	us-gaap	Prepaid Rent PrepaidRent	4659	usd
	xeri	Reacquisition Price Of Modified Convertible Debt Instrument1 ReacquisitionPriceOfModifiedConvertibleDebtInstrument1	5850000	usd
CY2023Q1	xeri	Operating Lease Right Of Use Asset Before Accumulated Amortization OperatingLeaseRightOfUseAssetBeforeAccumulatedAmortization	220448	usd
CY2023Q1	xeri	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	-125715	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	94733	usd
CY2023Q1	xeri	Office Leas OfficeLeas	105049	usd
CY2023Q1	xeri	Operating Lease Liability Current Portion OperatingLeaseLiabilityCurrentPortion	-54169	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	50880	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	15245	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	62201	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	37112	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	114558	usd
CY2023Q1	xeri	Present Value Discount PresentValueDiscount	-9509	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	105049	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	5850000	usd
CY2022Q2	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	3936185	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5850000	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	6050000	usd
CY2023Q1	xeri	Less Unamortized Discount LessUnamortizedDiscount	0	usd
CY2022Q2	xeri	Less Unamortized Discount LessUnamortizedDiscount	-2113815	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	5850000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3936185	usd
	xeri	Schedule Of Loss On Extinguishment On Convertible Debt Instrument ScheduleOfLossOnExtinguishmentOnConvertibleDebtInstrument	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Reacquisition Price:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Modified convertible debt instrument </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,950,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fair value of warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,918,393</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash payment </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">7,968,393</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Carrying Value of Original Instrument</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Original convertible debt instrument </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,050,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Debt discount - warrant </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(707,585 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Original issue discount </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(341,692 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Debt discount - BCF </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(602,696 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Carrying value of original debt </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">4,398,027</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loss on extinguishment </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,570,366</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Reacquisition Price:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Modified convertible debt instrument</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5,850,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Fair value of warrants </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">689,621</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued Short-term Liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">100,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6,639,621</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Carrying Value of Original Instrument</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Carrying value of original debt </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5,950,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Loss on extinguishment </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">689,621</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
	xeri	Reacquisition Price Of Modified Convertible Debt Instrument ReacquisitionPriceOfModifiedConvertibleDebtInstrument	5950000	usd
	xeri	Reacquisition Price Of Fair Value Of Warrants ReacquisitionPriceOfFairValueOfWarrants	1918393	usd
	xeri	Reacquisition Price Of Cash Payment ReacquisitionPriceOfCashPayment	100000	usd
	xeri	Reacquisition Price Costs ReacquisitionPriceCosts	7968393	usd
CY2023Q1	xeri	Original Convertible Debt Instrument Carrying Value OriginalConvertibleDebtInstrumentCarryingValue	6050000	usd
CY2023Q1	xeri	Debt Discount Warrant Carrying Value DebtDiscountWarrantCarryingValue	-707585	usd
CY2023Q1	xeri	Original Issue Discount Carrying Value OriginalIssueDiscountCarryingValue	-341692	usd
CY2023Q1	xeri	Debt Discount Bcf Carrying Value DebtDiscountBcfCarryingValue	-602696	usd
CY2023Q1	xeri	Carrying Value Of Original Debt CarryingValueOfOriginalDebt	4398027	usd
	xeri	Gains Losses On Extinguishment Of Debt1 GainsLossesOnExtinguishmentOfDebt1	3570366	usd
	xeri	Reacquisition Price Of Fair Value Of Warrants1 ReacquisitionPriceOfFairValueOfWarrants1	689621	usd
	xeri	Reacquisitionpriceofaccrued Short Term Liability ReacquisitionpriceofaccruedShortTermLiability	100000	usd
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
	xeri	Reacquisition Price Costs One ReacquisitionPriceCostsOne	6639621	usd
CY2023Q1	xeri	Carrying Value Of Original Debt1 CarryingValueOfOriginalDebt1	5950000	usd
	xeri	Loss On An Extinguishment LossOnAnExtinguishment	689621	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	461482	usd
CY2023Q1	xeri	Carrying Value Of Auctus Note CarryingValueOfAuctusNote	5900000	usd
CY2022Q2	xeri	Carrying Value Of Auctus Note CarryingValueOfAuctusNote	3936185	usd
CY2023Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	270000	usd
CY2022Q3	xeri	Exercise Price ExercisePrice	0.09
CY2022Q2	us-gaap	Convertible Debt ConvertibleDebt	0	usd
	xeri	Proceeds From Convertible Bridge Loans ProceedsFromConvertibleBridgeLoans	189885	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	3258	usd
	xeri	Decrease Increase In Fair Value Of Convertible Bridge Loans DecreaseIncreaseInFairValueOfConvertibleBridgeLoans	817	usd
CY2023Q1	us-gaap	Convertible Debt ConvertibleDebt	185810	usd
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0.00001
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	381933144	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	365239001	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	4308600	shares
CY2022	xeri	Proceeds From Warrants Exercises ProceedsFromWarrantsExercises	128550	usd
CY2022	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	4685615	shares
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	761954	usd
CY2022	xeri	Share Sold During Period ShareSoldDuringPeriod	39366666	shares
CY2022	xeri	Share Sold During Period Value ShareSoldDuringPeriodValue	2078500	usd
CY2022	xeri	Share Issued For Exchange Conversion ShareIssuedForExchangeConversion	7138000	shares
CY2022	xeri	Conversion Of Series A Preferred To Common Stocks Shares ConversionOfSeriesAPreferredToCommonStocksShares	7138	shares
CY2022	xeri	Common Stock Issued For Prior Period Conversions Principal And Interest CommonStockIssuedForPriorPeriodConversionsPrincipalAndInterest	10598544	shares
CY2022	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	167550	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	4985	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	535	usd
CY2022	xeri	Common Stock Share Issued For Conversion CommonStockShareIssuedForConversion	4229680	shares
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	250000	usd
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	3749	usd
CY2022	xeri	Shares Issued For Common Stock In Exchange For The Inducement SharesIssuedForCommonStockInExchangeForTheInducement	845936	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	134927	usd
CY2022Q3	xeri	Share Issued For Exchange Conversion ShareIssuedForExchangeConversion	1000000	shares
CY2022Q3	xeri	Conversion Of Series A Preferred To Common Stocks Shares ConversionOfSeriesAPreferredToCommonStocksShares	1000	shares
CY2022Q3	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	457143	shares
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	48000	usd
CY2022Q4	xeri	Share Issued For Exchange Conversion ShareIssuedForExchangeConversion	10237000	shares
CY2022Q4	xeri	Conversion Of Series A Preferred To Common Stocks Shares ConversionOfSeriesAPreferredToCommonStocksShares	10237	shares
CY2023Q1	xeri	Share Issued For Exchange Conversion ShareIssuedForExchangeConversion	5000000	shares
CY2023Q1	xeri	Conversion Of Series A Preferred To Common Stocks Shares ConversionOfSeriesAPreferredToCommonStocksShares	500	shares

Files In Submission

Name	View Source	Status
xeri-20230331_cal.xml	Edgar Link	unprocessable
0001477932-23-003889-index-headers.html	Edgar Link	pending
0001477932-23-003889-index.html	Edgar Link	pending
0001477932-23-003889.txt	Edgar Link	pending
0001477932-23-003889-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xeri-20230331.xsd	Edgar Link	pending
xeri_10q.htm	Edgar Link	pending
xeri_ex311.htm	Edgar Link	pending
xeri_ex312.htm	Edgar Link	pending
xeri_ex321.htm	Edgar Link	pending
xeri_ex322.htm	Edgar Link	pending
xeri-20230331_def.xml	Edgar Link	unprocessable
xeri-20230331_lab.xml	Edgar Link	unprocessable
xeri-20230331_pre.xml	Edgar Link	unprocessable
xeri_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XERI
XERIANT, INC. Stock $xeri

2023 Q2 Form 10-Q Financial Statement

#000147793223003889 Filed on May 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XERI XERIANT, INC. Stock $xeri

2023 Q2 Form 10-Q Financial Statement

#000147793223003889 Filed on May 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XERI
XERIANT, INC. Stock $xeri